Neurocrine Biosciences (NBIX) Treasury Shares: 2010-2020
Historic Treasury Shares for Neurocrine Biosciences (NBIX) over the last 5 years, with Dec 2020 value amounting to $1.5 million.
- Neurocrine Biosciences' Treasury Shares rose 7.14% to $1.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.5 million, marking a year-over-year increase of 7.14%. This contributed to the annual value of $1.5 million for FY2020, which is 7.14% up from last year.
- Per Neurocrine Biosciences' latest filing, its Treasury Shares stood at $1.5 million for Q4 2020, which was up 7.14% from $1.4 million recorded in Q4 2019.
- Over the past 5 years, Neurocrine Biosciences' Treasury Shares peaked at $1.5 million during Q4 2020, and registered a low of $200,000 during Q2 2017.
- In the last 3 years, Neurocrine Biosciences' Treasury Shares had a median value of $766,500 in 2018 and averaged $838,833.
- In the last 5 years, Neurocrine Biosciences' Treasury Shares plummeted by 50.00% in 2017 and then spiked by 50.00% in 2018.
- Over the past 5 years, Neurocrine Biosciences' Treasury Shares (Quarterly) stood at $883,000 in 2016, then increased by 22.31% to $1.1 million in 2017, then climbed by 4.91% to $1.1 million in 2018, then increased by 23.57% to $1.4 million in 2019, then increased by 7.14% to $1.5 million in 2020.
- Its Treasury Shares was $1.5 million in Q4 2020, compared to $1.4 million in Q4 2019 and $1.1 million in Q4 2018.